Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.

Goyard, David

Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition. [electronic resource] - European journal of medicinal chemistry Jan 2016 - 444-454 p. digital

Publication Type: Journal Article

1768-3254

10.1016/j.ejmech.2015.12.004 doi


Animals
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Disease Models, Animal
Dose-Response Relationship, Drug
Enzyme Inhibitors--chemical synthesis
Glucose--analogs & derivatives
Glycogen Phosphorylase--antagonists & inhibitors
Hypoglycemic Agents--chemical synthesis
Isoxazoles--chemical synthesis
Molecular Structure
Rats
Rats, Zucker
Spiro Compounds--chemical synthesis
Structure-Activity Relationship